Evidence map›Paper›PMID 40823391›Full record

ArticleChemistry of materials : a publication of the American Chemical Society2025

Functional Self-Immolative Hydrogels with Dendritic Cross-Linkers for Controlled Drug Delivery.

Silvia Muñoz-Sánchez, Jue Gong, Francisco Javier de la Mata, Elizabeth R Gillies, Sandra García-Gallego

Abstract read
In one paragraph

Article in Chemistry of materials : a publication of the American Chemical Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Silvia Muñoz-SánchezDepartment of Organic and Inorganic Chemistry and Research Institute in Chemistry ″Andrés M. Del Río″ (IQAR), University of Alcalá, 28805 Madrid, Spain.
Jue GongDepartment of Chemistry, The University of Western Ontario, London, Ontario N6A 5B7, Canada.
Francisco Javier de la MataDepartment of Organic and Inorganic Chemistry and Research Institute in Chemistry ″Andrés M. Del Río″ (IQAR), University of Alcalá, 28805 Madrid, Spain.ORCID https://orcid.org/0000-0003-0418-3935
Elizabeth R GilliesDepartment of Chemistry, The University of Western Ontario, London, Ontario N6A 5B7, Canada.ORCID https://orcid.org/0000-0002-3983-2248
Sandra García-GallegoDepartment of Organic and Inorganic Chemistry and Research Institute in Chemistry ″Andrés M. Del Río″ (IQAR), University of Alcalá, 28805 Madrid, Spain.ORCID https://orcid.org/0000-0001-6112-0450

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the biomedical field, the design of materials with controlled degradation is highly desired. Herein, we present a family of dendritic hydrogels accomplished through copper-assisted azide-alkyne cycloaddition click reaction between dendritic cross-linkers and complementary linear polymers. As cross-linkers, an innovative family of bifunctional carbosilane dendrimers was designed for this purpose, bearing multiple alkyne groups available for network formation as well as pendant hydroxyl groups for postfunctionalization. Additionally, different azide-pendant polymers were employed, including difunctional poly-(ethylene glycol) with cleavable and noncleavable nature, as well as poly-(ethyl glyoxylate) with and without self-immolative behavior. The rational design of the dendritic hydrogels, through the careful selection of these two components, enabled an accurate manipulation of properties like swelling and mechanical properties. The network degradation could be tuned from a few hours, for a traditional ester-cleavable dendritic hydrogel, to several days under pH-controlled conditions, for the self-immolative hydrogel (SIH). The impact of network degradation on the release of curcumin as a model drug was also confirmed. This work showcased the potential of dendritic SIHs for biomedical applications.

Identifiers

PMID40823391
PMCPMC12355646

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.